Navigation Links
New breast cancer drug on the block

A new drug has been approved in Scotland for the treatment of breast cancers in the early stages. The drug named Arimidex seems to be beneficial // specifically in treating breast cancer in women, who have crossed menopause. Arimidex is an aromatase inhibitor that works by inhibiting the oestrogen production in the adrenal gland.

Apparently more than 4,000 women are expected to benefit from the use of this drug. England and Wales also intend to introduce this drug into the market by the end of this year. Keeping in mind the efficacy that has been noted so far, this drug is also due for consideration for the approval by National Institute of Clinical Excellence.

The medical journal Lancet has reported that this drug has helped in halving the risk of the illness relapsing in patients. Lancet Oncology reports that recipients of this drug have shown remarkable improvement after two to three years following surgery, as compared to the standard drug of choice, Tamoxifen. Their chances of succumbing to death on account of the cancer were reduced by 29%.The study reported in Lancet also shows that chances of relapse were minimized by 45% after introduction of this drug. The long term chance of occurrence of any other cancer in the lifetime of the patient also showed a considerable decline of 39% in the studies.

Professor Walter Jonat, the author of the study is confident that this drug will enable the breast cancer patients to face their future with confidence.
MST
'"/>




Page: 1

Related medicine news :

1. Ductal lavage may detect early breast cancer
2. Exclusive breast-feeding advised for six months in infants recommends World Health Organization
3. Micro-camera provides new breast imaging technique
4. Support therapy helps breast cancer patients
5. Variation in breast cancer
6. Appropriate treatment for breast cancer
7. Combination therapy to treat breast cancer
8. Hope for breast cancer patients
9. Pregnancy weight linked to breast cancer
10. New breast cancer genes discovered
11. New breast cancer drug appears encouraging
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/21/2017)... ... May 20, 2017 , ... Pot. Reefer. Grass. Mary Jane. ... it, and share its attributes like never before. More than a map, new social ... enthusiasts to stores, strains, products – and for the first time – each other. ...
(Date:5/21/2017)... FL (PRWEB) , ... May 21, 2017 , ... Florida ... announce the opening of its newest location at 109 Silver Palm Ave., Melbourne, on ... Rodolfo Gari. , With the opening of the Melbourne practice, PPOA operates 23 pain ...
(Date:5/21/2017)... ... 21, 2017 , ... Following the tragic and widely publicized death of Rory ... require that hospitals follow a protocol to quickly identify and treat the condition. ... such steps would have saved Rory or anyone else’s life. , Now, five ...
(Date:5/19/2017)... ... 19, 2017 , ... In a continuous effort to raise awareness of autism ... company that specializes in natural and organic latex mattresses, has announced that they will ... unique share their recent viral Facebook video receives, up to $10,000.00. ...
(Date:5/19/2017)... ... 2017 , ... DMG Productions is proud to announce that ... Begley, Jr., airing fourth quarter 2017 on FOX Business. , Based in Jersey ... made from naturally occurring ingredients. Innovations will enlighten viewers on RawTrition’s all-in-one supplement ...
Breaking Medicine News(10 mins):
(Date:5/8/2017)... , May 8, 2017  Diplomat Pharmacy, Inc. ... Communications, Inc. ("WRB"), a health care service center ... WRB specializes in relationship management programs for ... WRB will join ... commercialization support services for manufacturers, biotech firms, and other ...
(Date:5/4/2017)... Tenn. , May 4, 2017  A ... Infection Control, Ultraviolet-C light as a ... Tru-D SmartUVC,s ability to reduce bioburden on anesthesia ... bioburden reduction on high-touch, complex medical equipment surfaces ... surgical infections. "This study further validates ...
(Date:5/4/2017)...   BioLife Solutions , Inc. (NASDAQ: ... proprietary clinical grade hypothermic storage and ... announced that the Company,s first quarter 2017 financial results ... 11, 2017, and that the Company will host a ... that afternoon. Management will provide an overview of the ...
Breaking Medicine Technology: